| Life Science
Reference Icons Advantages
Thuringia has always been at the forefront of the life sciences. It brought forth the mercury-free thermometer, the X-ray tube and the microscope. Today the use of photonic technologies enables major advances in the diagnosis and treatment of infections.
Thuringia has a long tradition in medical technology, biotechnology and pharmaceuticals. Its strengths in optics and photonics make Thuringia an international innovation leader in microscopy, laser technology and ophthalmology. Infection research and ageing research have been established in recent years and have gained international significance. It has also succeeded in attracting top research projects to Thuringia, e.g. the Cluster of Excellence “Balance of the Microverse” (approx. 47 million euros in funding for infection research) and the “Leibniz Center for Photonics in Infection Research (LPI)” with a funding volume of 150 million euros.
medways e. V. has been the industry association for medical technology and biotechnology in Thuringia for 25 years, connecting manufacturers, universities, and research institutions. In addition, medways advises companies in all phases of research, development, and marketing.
The InfectoGnostics research campus is a partnership between science, medicine and industry. Over 30 partners work together to develop innovative, cost-effective solutions for the rapid on-site diagnosis of infections and quickly transfer research findings into practice.
In the Thuringian pharmaceutical community, many players such as companies, universities, research institutions and clinics are committed to the further development of active pharmaceutical ingredients and technologies.
OptoNet e.V. brings together 140 leading players from industry, research and education in the field of photonics. Together, we are committed to further strengthening the high-tech location in the heart of Germany and shaping the future sustainably with innovative light-based technologies.
Selected companies Thuringia offers excellent growth opportunities in medical technology, biotechnology, and pharmaceuticals. Renowned market and technology leaders are committed to this location.
Abbott Rapid Diagnostics Jena GmbH
The company was founded by scientists from the Leibniz Institute of Photonic Technology and the Hans Knöll Institute and focuses on the development and production of in-vitro diagnostics. Since 2017, it has been part of the Abbott Group, one of the world's leading companies in the field of point-of-care solutions.
AEROPHARM GmbH
AEROPHARM is the Sandoz Group's global center for respiratory and ophthalmic medicines. At our site in Rudolstadt, Thuringia, around 280 employees currently develop, produce and package 15 million respiratory medicines per year, such as asthma sprays or innovative dry powder inhalers. In addition, innovative solutions are developed in the indication areas of asthma and COPD (chronic obstructive pulmonary disease).
Analytik Jena GmbH & Co. KG
As a globally active and leading provider of analytical measurement technology, molecular biology instruments, liquid handling and laboratory automation technologies, Analytik Jena enables laboratories around the world to work quickly and successfully - from routine analysis to specialized tasks in the fields of chemistry, pharmaceuticals, medicine and life science, food safety and agriculture, water and wastewater analysis, environmental analysis and much more. The company has been part of the Swiss Endress+Hauser Group since 2013.
Bauerfeind AG
Bauerfeind AG is one of the leading manufacturers of medical aids such as supports, orthoses, compression stockings and orthopaedic insoles. The products, which have received numerous awards for their materials and design, make an important contribution to maintaining and restoring health.
Carl Zeiss Meditec AG
The long-term goal of Carl Zeiss Meditec AG is to leave a lasting mark in the fields of ophthalmology and microsurgery. With its ambition to break new ground, the company develops innovative technologies, which enable healthcare professionals, e.g. to preserve vision into old age and fight brain tumors.
Wacker Biotech GmbH
Since 2005, WACKER has been producing high-quality biopharmaceuticals based on microbial systems in Jena. The highly specialized production facility focuses on the contract development and production of therapeutic proteins. The solutions developed in Jena make a decisive contribution to the treatment of serious diseases, such as lymphocytic leukemia in children and teens.

















